Literature DB >> 30176533

The lack of PI3Kγ favors M1 macrophage polarization and does not prevent kidney diseases progression.

Mariane T Amano1, Angela Castoldi2, Vinicius Andrade-Oliveira2, Marcela T Latancia3, Fernanda F Terra2, Matheus Correa-Costa2, Cristiane N S Breda2, Raphael J F Felizardo2, Welbert O Pereira4, Marina B da Silva2, Mariana Y S Miyagi2, Cristhiane F Aguiar2, Meire I Hiyane2, João S Silva5, Ivan C Moura6, Niels O S Camara7.   

Abstract

Acute kidney injury (AKI) and chronic kidney disease (CKD) are major concerns in worldwide public health, and their pathophysiology involves immune cells activation, being macrophages one of the main players of both processes. It is suggested that metabolic pathways could contribute to macrophage modulation and phosphatidylinositol‑3 kinase (PI3K) pathway was shown to be activated in kidneys subjected to ischemia and reperfusion as well as unilateral ureteral obstruction (UUO). Although PI3K inhibition is mostly associated with anti-inflammatory response, its use in kidney injuries has been shown controversial results, which indicates the need for further studies. Our aim was to unveil the role of PI3Kγ in macrophage polarization and in kidney diseases development. We analyzed bone-marrow macrophages polarization from wild-type (WT) and PI3Kγ knockout (PI3K KO) animals. We observed increased expression of M1 (CD86, CCR7, iNOS, TNF, CXCL9, CXCL10, IL-12 and IL-23) and decreased of M2 (CD206, Arg-1, FIZZ1 and YM1) markers in the lack of PI3Kγ. And this modulation was accompanied by higher levels of inflammatory cytokines in PI3K KO M1 cells. PI3K KO mice had increased M1 in steady state kidneys, and no protection was observed in these mice after acute and chronic kidney insults. On the contrary, they presented higher levels of protein-to-creatinine ratio and Kim-1 expression and increased tubular injury. In conclusion, our findings demonstrated that the lack of PI3Kγ favors M1 macrophages polarization providing an inflammatory-prone environment, which does not prevent kidney diseases progression.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Chronic kidney disease; Macrophage; PI3K

Mesh:

Substances:

Year:  2018        PMID: 30176533     DOI: 10.1016/j.intimp.2018.08.020

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

Review 1.  Macrophage polarization in chronic kidney disease: a balancing act between renal recovery and decline?

Authors:  Jason E Engel; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

2.  Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection.

Authors:  Young Jae Kim; June-Young Lee; Jae Jin Lee; Sang Min Jeon; Prashanta Silwal; In Soo Kim; Hyeon Ji Kim; Cho Rong Park; Chaeuk Chung; Jeong Eun Han; Jee-Won Choi; Euon Jung Tak; Ji-Ho Yoo; Su-Won Jeong; Do-Yeon Kim; Warisa Ketphan; Su-Young Kim; Byung Woo Jhun; Jake Whang; Jin-Man Kim; Hyungjin Eoh; Jin-Woo Bae; Eun-Kyeong Jo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 3.  Inflammation in Renal Diseases: New and Old Players.

Authors:  Vinicius Andrade-Oliveira; Orestes Foresto-Neto; Ingrid Kazue Mizuno Watanabe; Roberto Zatz; Niels Olsen Saraiva Câmara
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

4.  The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype.

Authors:  Yingying Sun; Xiaoqing Han; Chao Shang; Yawei Wang; Boya Xu; Shu Jiang; Yan Mo; Dake Wang; Yueshuang Ke; Xianlu Zeng
Journal:  Cell Death Dis       Date:  2022-01-10       Impact factor: 8.469

Review 5.  Phenotype Diversity of Macrophages in Osteoarthritis: Implications for Development of Macrophage Modulating Therapies.

Authors:  Nataliya V Mushenkova; Nikita G Nikiforov; Nikolay K Shakhpazyan; Varvara A Orekhova; Nikolay K Sadykhov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

Review 6.  Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword.

Authors:  Mengwan Wu; Ying Shi; Luyi Zhu; Luoyi Chen; Xinchen Zhao; Chuan Xu
Journal:  Life (Basel)       Date:  2022-08-12

Review 7.  Macrophage: A Potential Target on Cartilage Regeneration.

Authors:  Tiago Lazzaretti Fernandes; Andreas H Gomoll; Christian Lattermann; Arnaldo Jose Hernandez; Daniela Franco Bueno; Mariane Tami Amano
Journal:  Front Immunol       Date:  2020-02-11       Impact factor: 7.561

8.  Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.

Authors:  Meng-Xi Xiu; Zu-Ting Liu; Jian Tang
Journal:  Int Immunopharmacol       Date:  2020-08-10       Impact factor: 4.932

Review 9.  Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.

Authors:  Botle Precious Setlai; Rodney Hull; Meshack Bida; Chrisna Durandt; Thanyani Victor Mulaudzi; Aristotelis Chatziioannou; Zodwa Dlamini
Journal:  Biomedicines       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.